caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1891795852

Mark DabagiaMD

UrologyFort Wayne, INI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
802
Unique beneficiaries
—
Total services
1,100
Distinct HCPCS
17
Medicare payment
$96K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 211 Urology providers in IN — below median (cohort median 2,884).
REFERRAL NETWORK

Where Mark Dabagia's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 21 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
IOM HEALTH SYSTEM LP135604
PARKVIEW HOSPITAL, INC.33115
John Ducker
Nephrology · Fort Wayne, IN
27325
David Pollifrone
Urology · Fort Wayne, IN
2368
Pathology Laboratories, Inc.
Clinical Laboratory · Toledo, OH
2170
Pamela Coleman
Pathology · Houston, TX
2044
Gita Singh
Obstetrics & Gynecology · Fort Wayne, IN
2064
Adam Thomas
Urology · Fort Wayne, IN
2065
BLUFFTON HEALTH SYSTEM LLC1889
Dakshesh Patel
Diagnostic Radiology · Fort Wayne, IN
1740
WAGNER, SCOTT1637
James Arata
Diagnostic Radiology · Fort Wayne, IN
1640
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
Final MIPS score
83.5
Quality
70.0
Cost
75.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.36%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
1,050
Beneficiaries
—
Total drug cost
$244K
Distinct drugs
12
Brand share
9.9%
Top prescribed drugs
Tamsulosin Hcl374 claims
Finasteride364 claims
Ciprofloxacin Hcl75 claims
Sulfamethoxazole/Trimethoprim59 claims
Cephalexin50 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$14K
Payment records
21
By payment type
Consulting Fee$11K
Education$2K
Travel and Lodging$1K
Food and Beverage$185